about
Biosynthesis and Reactivity of Cysteine Persulfides in SignalingAssociating mutations causing cystinuria with disease severity with the aim of providing precision medicine.How should patients with cystine stone disease be evaluated and treated in the twenty-first century?Inhibition of urinary macromolecule heparin on aggregation of nano-COM and nano-COD crystals.Clinical outcomes for cystinuria patients with unilateral versus bilateral cystine stone disease.Natural history and quality of life in patients with cystine urolithiasis: a single centre study.The genetic diversity of cystinuria in a UK population of patients.
P2860
Q36695581-AA643A4C-318D-42F2-A21D-8C44F4BD5460Q38622499-2A9E749B-310E-4F29-BA93-42FECDD31C93Q38650736-AFC0677E-4D42-4D41-818B-797DB8DF1F42Q46282194-DE18EC87-8CBF-4C1E-9459-B00B36B0DB6BQ46630558-4238593C-5532-42C6-AB6A-1CD01C009D01Q48004411-919E1F4E-C245-4749-9606-A1282B23D6CEQ54195283-3ADBB344-FDDD-40D0-8FFE-5DDF8E0C0017
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cystinuria-a urologist's perspective.
@en
type
label
Cystinuria-a urologist's perspective.
@en
prefLabel
Cystinuria-a urologist's perspective.
@en
P2093
P2860
P356
P1476
Cystinuria-a urologist's perspective.
@en
P2093
Angela Doherty
John Withington
Kathie Wong
Kay Thomas
Matthew Bultitude
P2860
P2888
P304
P356
10.1038/NRUROL.2014.51
P407
P577
2014-03-25T00:00:00Z
P5875
P6179
1051511688